More Downside for Sequenom ?

General Motors (GM)

General Electric (GE)

Apple (AAPL)

Deere (DE)

JP Morgan (JPM)

S&P Indices Announces Changes to U.S. Indices

Staples, Inc. Announces First Quarter 2012 Performance

Xerox Broke Support

Are the Bears Taking Control over F5 Networks?

Chico's FAS Reports First Quarter Earnings

More Downside for Sequenom ?

Published on Wednesday, 23 November 2011 11:34 Written by TradersHuddle Staff

sqnm New York, November 23rd (TradersHuddle.com) - Shares of Sequenom Inc. (NASDAQ:SQNM) booked a new 52 week low by trading below $3.95, traders are definitely monitoring Sequenom's price action to see if this move attracts further selling, or it this last push down sets a tradable bottom in the stock.

Sequenom Inc. (NASDAQ:SQNM) provides genetic analysis products that translate genomic science into solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research.

Sequenom is currently trading -5.56% versus its previous trading session close, and it has calculated support and resistance at $3.95 and $4.38 respectively. Clearly with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range

The overall market index S&P 500 is trading lower by -1.8% from its previous trading close, which means that Sequenom stock is underperforming the overall market.

A 52 Week Low for Sequenom

Sequenom Provides Update on Agreement With Coventry Health Care - Benzinga
Sequenom Inc. (SQNM): Today's Featured Drugs Winner - TheStreet.com
UPDATE: Oppenheimer Raises PT of Sequenom to $10 - Benzinga
Sequenom Stock Hits New 52-Week Low (SQNM) - TheStreet.com
Wedbush: Sequenom Has No Room for Missteps - Benzinga
Wedbush: Sequenom 4Q11 Preview - Benzinga
Oppenheimer Reports that Sequenom Is Filing an Injunction against Aria Diagnostics - Benzinga
From Earlier: Sequenom Files Motion for Preliminary Injunction Against Aria Diagnostics - Benzinga
Sequenom Announces Study Published In Genetics In Medicine Demonstrates Sequenom CMM MaterniT21 Test Accurately Detects Two Additional Fetal Trisomies - Benzinga
Sequenom Stock Falls On Unusually High Volume (SQNM) - TheStreet.com

Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits. Try it FREE!